Poly(Lactic-co-Glycolic) Acid as a Carrier for Imaging Contrast Agents

被引:59
作者
Doiron, Amber L. [2 ]
Homan, Kimberly A. [2 ]
Emelianov, Stanislav [2 ]
Brannon-Peppas, Lisa [1 ]
机构
[1] Appian Labs, Austin, TX USA
[2] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
fluorescence; Gd-DTPA; magnetic resonance imaging (MRI); photoacoustic ultrasound (PAUS) imaging; silver; DRUG-DELIVERY; PROTEIN ENCAPSULATION; NANOPARTICLES; SILVER; MICROPARTICLES; RELEASE; CANCER; ULTRASOUND; THERAPY; SYSTEM;
D O I
10.1007/s11095-008-9786-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With the broadening field of nanomedicine poised for future molecular level therapeutics, nano- and microparticles intended for the augmentation of either single- or multimodal imaging are created with PLGA as the chief constituent and carrier. Emulsion techniques were used to encapsulate hydrophilic and hydrophobic imaging contrast agents in PLGA particles. The imaging contrast properties of these PLGA particles were further enhanced by reducing silver onto the PLGA surface, creating a silver cage around the polymeric core. The MRI contrast agent Gd-DTPA and the exogenous dye rhodamine 6G were both encapsulated in PLGA and shown to enhance MR and fluorescence contrast, respectively. The silver nanocage built around PLGA nanoparticles exhibited strong near infrared light absorbance properties, making it a suitable contrast agent for optical imaging strategies such as photoacoustic imaging. The biodegradable polymer PLGA is an extremely versatile nano- and micro-carrier for several imaging contrast agents with the possibility of targeting diseased states at a molecular level.
引用
收藏
页码:674 / 682
页数:9
相关论文
共 46 条
[31]   Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives [J].
Mundargi, Raghavendra C. ;
Babu, V. Ramesh ;
Rangaswamy, Vidhya ;
Patel, Pradip ;
Aminabhavi, Tejraj M. .
JOURNAL OF CONTROLLED RELEASE, 2008, 125 (03) :193-209
[32]   Combined ultrasound and optoacoustic system for real-time high-contrast vascular imaging in vivo [J].
Niederhauser, JJ ;
Jaeger, M ;
Lemor, R ;
Weber, P ;
Frenz, M .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2005, 24 (04) :436-440
[33]   Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles [J].
Owens, DE ;
Peppas, NA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (01) :93-102
[34]   Biodegradable nanoparticles for drug and gene delivery to cells and tissue [J].
Panyam, J ;
Labhasetwar, V .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (03) :329-347
[35]   Gadolinium DTPA-monoamide complexes incorporated into mixed micelles as possible MRI contrast agents [J].
Parac-Vogt, TN ;
Kimpe, K ;
Laurent, S ;
Piérart, C ;
Elst, LV ;
Muller, RN ;
Binnemans, K .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2004, (17) :3538-3543
[36]  
PARK S, 2006, P SOC PHOTO-OPT INS, V6147, P148
[37]   A tumor-targeted nanodelivery system to improve early MRI detection of cancer [J].
Pirollo, Kathleen F. ;
Dagata, John ;
Wang, Paul ;
Freedman, Matthew ;
Vladar, Andras ;
Fricke, Stanley ;
Ileva, Lilia ;
Zhou, Qi ;
Chang, Esther H. .
MOLECULAR IMAGING, 2006, 5 (01) :41-52
[38]   Photoinduced formation of gold nanoparticles into vinyl alcohol based polymers [J].
Pucci, A ;
Bernabò, M ;
Elvati, P ;
Meza, LI ;
Galembeck, F ;
Leite, CAD ;
Tirelli, N ;
Ruggeri, G .
JOURNAL OF MATERIALS CHEMISTRY, 2006, 16 (11) :1058-1066
[39]  
Quellec P, 1998, J BIOMED MATER RES, V42, P45, DOI 10.1002/(SICI)1097-4636(199810)42:1<45::AID-JBM7>3.0.CO
[40]  
2-O